Bracco Imaging, NYU Langone Health Form Strategic Research Alliance to Drive Imaging Innovation

Bracco Imaging has announced a strategic alliance with NYU Langone Health, formalized through a multi-year Master Research Agreement (MRA), aimed at accelerating innovation across key areas of diagnostic imaging.

The collaboration will combine Bracco’s expertise in contrast imaging and diagnostic solutions with NYU Langone Health’s clinical and academic leadership to develop and optimize advanced imaging technologies. The goal is to enhance clinical insights, improve patient management, and support more precise and timely medical decision-making.

The partnership will focus on several high-impact imaging modalities, including Magnetic Resonance Imaging (MRI), Photon-Counting Computed Tomography (PCCT), targeted ultrasound, and artificial intelligence-enabled analysis for PET/CT and MRI. Both organizations say the effort is designed to strengthen precision medicine by translating research breakthroughs into real-world clinical applications.

“The agreement reflects a shared commitment between the Bracco Group and NYU Langone Health to advance research and clinical innovation in medical imaging,” said Fulvio Renoldi Bracco, Vice Chairman and CEO of Bracco Imaging. He added that the collaboration aims to “further enhance diagnostic performance, streamline clinical workflows and ultimately generate meaningful impact for patients and healthcare systems.”
NYU Langone Health, widely recognized as a global leader in radiology and translational research, will play a central role in bridging scientific discovery and clinical implementation. The agreement is structured to foster closer integration between research and practice, leveraging the institution’s strengths in combining advanced technologies with patient care.

“Diagnostic imaging is advancing at a remarkable pace, and strategic collaborations are essential to progress,” said Michael P. Recht, MD, the Louis Marx Professor of Radiology and chair of the Department of Radiology at NYU Grossman School of Medicine. “We are excited to build on NYU Langone Health's legacy of advances and to work with The Bracco Group toward breakthroughs in modalities central to precision medicine in terms of superior diagnostic accuracy and enhanced clinical decision-making.”

The alliance underscores a growing trend of industry-academic partnerships aimed at accelerating innovation in healthcare and delivering more effective, data-driven patient care solutions.